Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04680663
Other study ID # MS-390-2020
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date January 1, 2021
Est. completion date January 1, 2022

Study information

Verified date December 2020
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Many patients undergoing long time surgery will manifest increased level of blood lactate. Hyperlactacidemia can cause disturbance of internal environment, then leading to increased complications and longer ICU stay, even death. For postoperative patients, we must ensure adequate perfusion in order to minimize the length of hyperglycemia and improve patients' outcomes. With regard to lactate, it provides information about prefusion, but not timely enough for its delay on reflecting hypoperfusion. And it's not real-time and non-invasive. Peripheral perfusion index (PPI) is an indicator reflecting hypoperfusion in critical patients. It is measured using pulse co-oximetry technology which is characterized by being real-time and noninvasive. PPI is defined as "the ratio of pulsatile blood flow to the non-pulsatile blood flow", mirroring the strength of blood flow and quality of perfusion at sensor site, reflecting perfusion state of the body part . In contrast to lactate value, it's real-time and easy to monitor.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 102
Est. completion date January 1, 2022
Est. primary completion date December 1, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility - Inclusion criteria - Adult patients above 18 years of age. - Both genders - surgical time planned to be > 120 minutes . - surgical time predicted to exceed the planned time and prolongation of surgical time > 120 minutes occured will be included in the study . - ASA physical status of I-III - Patients scheduled for elective surgery under general anaesthesia . - Exclusion criteria - Refused to participate . - ASA physical status of IV . - patient with disease affecting blood flow to the hands where probe will be applied . - patient with hand injuries so probe cannot be applied - Patient with sever renal and liver disease - Discharging against medical advice or reported death during ICU stay at first 48 hours after ICU admission . - Pregnancyor emergency surgery . - shortening of the planned surgical time to be less than 120 minutes due to a surgical factor for example irrespectability or other causes .

Study Design


Intervention

Diagnostic Test:
Peripheral Perfusion index
Peripheral Perfusion index is the ratio between pulsatile blood flow to non pulsatile blood flow or static blood in the peripheral tissue
serum lactate level
Blood lactate (product of metabolism) level is maintained by a cycle of continuous production and metabolism allowing it to be kept within normal values

Locations

Country Name City State
Egypt Cairo university Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary serum lactate level at end of surgery as early predictor of postoperative complications . UP TO 1 HOURE
Primary Peripheral perfusion index at end of surgery as early predictor of postoperative complications . UP TO 1 HOURE
Secondary Length of ICU stay BY DAY UP TO 30 DAY
Secondary hospital stay length BY DAY UP TO 30 DAY
Secondary duration of surgical time MIN UP TO 24 HOURE